| 1. |
- Almquist, Helén, et al.
(författare)
-
Quantitative SPECT by attenuation correction of the projection set using transmission data: evaluation of a method
- 1990
-
Ingår i: European Journal Of Nuclear Medicine. - 1432-105X. ; 16:8-10, s. 587-594
-
Tidskriftsartikel (refereegranskat)abstract
- A method for measuring attenuation coefficients in single-photon emission tomography (SPECT) is described and evaluated, together with a method for attenuation correction using these measured attenuation coefficients. Build-up, caused by scattered photons, is corrected for by a simple substitution in the algorithms. Transmission studies are performed with a 99mTc- or 57Co flood source, and emission phantom studies with 99mTc line sources. The method is evaluated with variable but well-defined phantoms. The result is accurate attenuation coefficients for different densities, dimensions and geometries, and an accuracy of corrected emission activities of better than +/- 10% in most cases. The present limitations of the method for attenuation correction are discussed.
|
|
| 2. |
- Andersson, JLR, et al.
(författare)
-
A multivariate approach to registration of dissimilar tomographic images
- 1999
-
Ingår i: European Journal of Nuclear Medicine. - : SPRINGER VERLAG. - 0340-6997 .- 1432-105X .- 1619-7070 .- 1619-7089. ; 26:7, s. 718-733
-
Tidskriftsartikel (refereegranskat)abstract
- We devised a method to allow for retrospective registration of tomographic images with very different information content, the main emphasis being on sets of positron emission tomography images obtained with different tracers. A multivariate cost-function
|
|
| 3. |
- Ceberg, Crister, et al.
(författare)
-
A new method for quantification of image distortion due to pile-up in scintillation cameras
- 1991
-
Ingår i: European Journal Of Nuclear Medicine. - 1432-105X. ; 18:12, s. 959-963
-
Tidskriftsartikel (refereegranskat)abstract
- Characterization of the count-rate performance of scintillation cameras should include not only the specification of count losses. At high count rates, there is also an image distortion due to the mispositioning of pile-up events. In this paper a simple and clinically relevant procedure to quantify this distortion is presented. The images of a square uniform technetium-99m phantom at high and low count rates are used. The fraction of the total counts being correctly positioned is determined as the peripheral count density divided by the total average count density. This ratio, corrected for the camera non-uniformity at low count rates, is called the 'positioning ability'. According to the National Electrical Manufacturers' Association (NEMA), the 'system count rate performance with scatter' should be reported as the measured count rate giving 20% count losses. In this paper it is suggested that this measure be complemented by a measure of the fraction correct positioned events at this count rate. This fraction, the 'high count rate positioning ability', can be easily and accurately measured using our method. The method has been tested on two different scintillation cameras. For one of them the high count rate positioning ability was determined as 91% at a measured count rate of 30,000 s-1 with 20% count losses. For the other camera, the corresponding figures were 88% at 59,000 s-1 and close to 100% at 38,000 s-1, before and after the installation of a new pile-up rejection circuit, respectively.
|
|
| 4. |
|
|
| 5. |
- Dewaraja, Yuni K., et al.
(författare)
-
Monte Carlo evaluation of object shape effects in iodine-131 SPET tumor activity quantification
- 2001
-
Ingår i: European Journal Of Nuclear Medicine. - : Springer Science and Business Media LLC. - 1432-105X .- 0340-6997 .- 1619-7089. ; 28:7, s. 900-906
-
Tidskriftsartikel (refereegranskat)abstract
- In our clinical iodine-131 single-photon emission tomography (SPET) quantification for radioimmunotherapy, calibration and partial volume correction are based on measurements with phantoms containing spheres to simulate patient tumors even though real tumors are frequently nonspherical. In this study, Monte Carlo simulation was used to evaluate how object shape influences "spill-out" and "spill-in", which are major sources of quantification error associated with the poor spatial resolution of 131I SPET. Objects that varied in shape (spheres, cylinders, and an irregular structure) but were identical in activity and volume were simulated. Iterative reconstruction employed both attenuation and triple-energy-window scatter compensation. VOIs were defined in the reconstructed images both using physical boundaries and using expanded boundaries to allow for the limited resolution. When physical boundaries were used, both spill-out and spill-in were more significant for nonspherical structures than for spherical structures. Over the range of object volumes (50-200 ml) and at all background levels, VOI counts in cylinders were lower than VOI counts in spheres. This underestimation increased with decrease in object size (for the cold background -18% at 200 ml and -39% at 50 ml). It also decreased with increase in background activity because spill-in partially compensated for spill-out. It was shown that with a VOI larger than physical size, the results are independent of object shape and size only in the case of cold background. Activity quantification was carried out using a procedure similar to that used in our clinic. Quantification of nonspherical objects was improved by simple sphere-based partial volume correction, but the error was still large in some cases (for example, -39% for a 50-ml cylinder in a cold background and -35% for a 200-ml irregular structure defined on the basis of a typical tumor outlined on an X-ray computed tomography scan of a patient with non-Hodgkin's lymphoma). Partial volume correction by patient-specific Monte Carlo simulation may provide better quantification accuracy.
|
|
| 6. |
|
|
| 7. |
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
|
|
| 11. |
|
|
| 12. |
- Kimiaei, Shahrok, et al.
(författare)
-
Evaluation of optimally designed planar-concave collimators in single-photon emission tomography
- 1997
-
Ingår i: European Journal Of Nuclear Medicine. - : Springer Science and Business Media LLC. - 1432-105X .- 1619-7070 .- 1619-7089. ; 24:11, s. 1398-1404
-
Tidskriftsartikel (refereegranskat)abstract
- The imaging properties of optimally designed planar-concave (PC) collimators were evaluated by means of Monte Carlo simulations. The evaluation was done with respect to total system spatial resolution and the overall image noise distribution in single-photon emission tomography. The results showed that the non-isotropy with PC collimators, assessed by the ratio of the full-width at half-maximum in the radial and tangential directions, was reduced by about 60% as compared with a conventional parallel-hole collimator for sources located 200 mm away from the centre of rotation. Furthermore, the image noise distribution along the object radius became more uniform when the curved collimator was used. The maximum increase in noise due to use of the curved collimator was about 45% close to the edge of the phantom, where the hole length was about 3 times longer. We also showed with Monte Carlo simulations that the spatial resolution of the lateral cortex when using the curved collimator was significantly improved due to improved radial resolution.
|
|
| 13. |
- Ljungberg, Michael, et al.
(författare)
-
Quantitative single photon emission tomography: verification for sources in an elliptical water phantom
- 1992
-
Ingår i: European Journal Of Nuclear Medicine. - 1432-105X. ; 19:10, s. 838-844
-
Tidskriftsartikel (refereegranskat)abstract
- Accurate absorbed dose calculations are important for a proper dose planning in internal radionuclide therapy. The activity distribution must be measured and the target volume defined. This can be done with single photon emission tomography (SPET) if proper attenuation and scatter correction are employed. This study investigated the calculation of the activity and the volume of different spherical sources. These two parameters are essential for a proper dose calculation. The scatter and attenuation correction method is based on spatially variant scatter functions and density maps. The volume calculation method is based on obtaining a threshold from a grey-level histogram. Both point sources and spheres of different diameters containing technetium-99m were placed in different locations in an elliptical water phantom and imaged by SPET. The activity and the volume of the spheres were calculated from the SPET images and compared with known activities. Results show a quantification of activity within 10% for most of the sources. Important influences on the quantification are (a) the presence of artefacts due to improper reconstruction and (b) the finite spatial resolution which affects the total number of counts within the determined volume.
|
|
| 14. |
|
|
| 15. |
- Noz, Marilyn E., et al.
(författare)
-
An integrated approach to biodistribution radiation absorbed dose estimates
- 1993
-
Ingår i: European Journal of Nuclear Medicine. - 0340-6997 .- 1432-105X. ; 20:2, s. 165-169
-
Tidskriftsartikel (refereegranskat)abstract
- An integrated approach to existing methods of extracting biodistribution data, pharmacokinetics and radiation absorbed dose estimates from serial scintigraphic images is described. This approach employs a single computer-generated user interface to reformat planar scans into a standard file type, align conjugate (anterior and posterior) images, draw regions of interest {(ROIs)} over selected organs and lesions and generate count data for anterior and posterior views and calculated geometric means. Using standard correction methods, the fraction injected activity is obtained for all {ROIs} and total body. This methodology has been applied to the analysis of {indium-III-labelled} breast-cancer-directed antibodies and technetium-90m-labelled {CEA-specific} antibody fragments in non-small-cell lung cancer. It is anticipated that this approach will be useful for evaluating the dosimetry of other radiolabelled monoclonal antibodies, as well as other radiopharmaceuticals.}
|
|
| 16. |
|
|
| 17. |
- Orlova, Anna, et al.
(författare)
-
On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors : Direct Comparison of a (124)I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
- 2009
-
Ingår i: Journal of Nuclear Medicine. - : Society of Nuclear Medicine. - 0161-5505 .- 1535-5667 .- 2159-662X .- 0340-6997 .- 1432-105X. ; 50:3, s. 417-425
-
Tidskriftsartikel (refereegranskat)abstract
- Human epidermal growth factor receptor type 2 (HER2) is a tyrosine kinase, which is often overexpressed in many carcinomas. Imaging HER2 expression in malignant tumors can provide important prognostic and predictive diagnostic information. The use of anti-HER2 tracers labeled with positron-emitting radionuclides may increase the sensitivity of HER2 imaging. The goal of this study was to compare directly 2 approaches for developing anti-HER2 PET tracers: a (124)I-labeled monoclonal antibody and a small (7-kDa) scaffold protein, the Affibody molecule, Methods: The anti-HER2 Affibody Z(HER2:342) and humanized monoclonal antibody trastuzumab were labeled with (124/125)I using p-iodobenzoate (PIB) as a linker. Cellular processing of both tracers by HER2-expressing cells was investigated. The biodistributions of (124)I-PIB-Z(HER2:342) and (125)I-PIB-trastuzumab were compared in BALB/C nu/nu mice bearing HER2-expressing NCI-N87 xenografts using paired labels. Small-animal PET of (124)I-PIB-Z(HER2:342) and (124)I-PIB-trastuzumab in tumor-bearing mice was performed at 6, 24, and 72 h after injection. Results: Both radioiodinated Z(HER2:342) and trastuzumab bound specifically to HER2-expressing cells in vitro and specifically targeted HER2-expressing xenografts in vivo. Radioiodinated trastuzumab was more rapidly internalized and degraded, which resulted in better retention of radioactivity delivered by Z(HER2:342). Total uptake of trastuzumab in tumors was higher than that of (124)I-PIB-Z(HER2:342). However, tumor-to-organ ratios were appreciably higher for (124)I-PIB-Z(HER2:342) due to the more rapid clearance of radioactivity from blood and normal organs. The ex vivo results were confirmed by small-animal PET. Conclusion: The use of the small scaffold targeting Affibody provides better contrast in HER2 imaging than does the monoclonal antibody.
|
|
| 18. |
|
|
| 19. |
- Ribom, Dan, et al.
(författare)
-
Potential significance of 11C-methionine PET as a marker for the radiosensitivity of low-grade gliomas
- 2002
-
Ingår i: European Journal of Nuclear Medicine. - : Springer Science and Business Media LLC. - 0340-6997 .- 1432-105X .- 1619-7070 .- 1619-7089. ; 29:5, s. 632-640
-
Tidskriftsartikel (refereegranskat)abstract
- The role for radiotherapy in patients with low-grade gliomas remains controversial. Two large prospective studies have failed to demonstrate a radiotherapeutic dose-response effect, and EORTC trial 22845 found no difference in survival between patients receiving adjuvant radiotherapy and those who received radiotherapy at tumour progression. The aim of this retrospective study was to analyse the patterns of carbon-11 methionine (MET) uptake on positron emission tomography (PET) in tumours treated with immediate radiotherapy and in those treated with delayed radiotherapy at the time of tumour progression. The 21 adult patients studied had histologically confirmed low-grade gliomas and had undergone a pre-treatment PET scan and a follow-up PET scan at the time of progression. Eleven of the patients had undergone initial radiotherapy a median of 5 weeks after the surgical procedure. The median time to progression was 3.5 years for this group, compared with 1.6 years for the group with delayed radiotherapy ( P=0.06). At the time of progression, non-irradiated tumours had a significantly higher MET uptake ( P=0.02) and a larger uptake volume ( P=0.008) compared with baseline, whereas irradiated tumours showed no statistically significant change. We observed a correlation between high pre-treatment uptake of MET and reduction in MET uptake in response to radiotherapy ( P=0.008). All irradiated tumours recurred within the radiation field. In conclusion, our results demonstrate signs of a residual radiation effect at the time of tumour progression in low-grade gliomas with high pre-treatment uptake of MET. Pre-treatment methionine uptake may be a marker for the radiosensitivity of low-grade gliomas.
|
|
| 20. |
- Rydh, Anders, et al.
(författare)
-
Serum amyloid P component scintigraphy in familial amyloid polyneuropathy : regression of visceral amyloid following liver transplantation.
- 1998
-
Ingår i: European Journal of Nuclear Medicine. - 0340-6997 .- 1432-105X. ; 25:7, s. 709-713
-
Tidskriftsartikel (refereegranskat)abstract
- Familial amyloid polyneuropathy (FAP) associated with transthyretin (TTR) mutations is the commonest type of hereditary amyloidosis. Plasma TTR is produced almost exclusively in the liver and orthotopic liver transplantation is the only available treatment, although the clinical outcome varies. Serum amyloid P component (SAP) scintigraphy is a method for identifying and quantitatively monitoring amyloid deposits in vivo, but it has not previously been used to study the outcome of visceral amyloid deposits in FAP following liver transplantation. Whole body scintigraphy following injection of iodine-123 labelled SAP was performed in 17 patients with FAP associated with TTR Met30 and in five asymptomatic gene carriers. Follow-up studies were performed in ten patients, eight of whom had undergone orthotopic liver transplantation 1-5 years beforehand. There was abnormal uptake of 123I-SAP in all FAP patients, including the kidneys in each case, the spleen in five cases and the adrenal glands in three cases. Renal amyloid deposits were also present in three of the asymptomatic carriers. Follow-up studies 1-5 years after liver transplantation showed that there had been substantial regression of the visceral amyloid deposits in two patients and modest improvement in three cases. The amyloid deposits were unchanged in two patients. In conclusion, 123I-SAP scintigraphy identified unsuspected visceral amyloid in each patient with FAP due to TTR Met30. The universal presence of renal amyloid probably underlies the high frequency of renal failure that occurs in FAP following liver transplantation. The variable capacity of patients to mobilise amyloid deposits following liver transplantation may contribute to their long-term clinical outcome.
|
|
| 21. |
- Sundberg, Åsa Liljegren, et al.
(författare)
-
Treatment of cultured glioma cells with EGFR-TKI gefitinib (‘Iressa’, ZD1839) increases the uptake of astatinated EGF despite absence of gefitinib-mediated growth inhibition
- 2003
-
Ingår i: European Journal of Nuclear Medicine. - : Springer Science and Business Media LLC. - 0340-6997 .- 1432-105X .- 1619-7070 .- 1619-7089. ; 30:5, s. 727-9
-
Tidskriftsartikel (refereegranskat)abstract
- The EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitor) gefitinib ("Iressa", ZD1839), a reversible growth inhibitor of EGFR-expressing tumour cells, has been shown to enhance the antitumour effect of ionising radiation, and also to increase the uptake of radioiodinated EGF. Thus, combination of gefitinib treatment and radionuclide targeting is an interesting option for therapy of brain tumours that are difficult to treat with conventional methods. The aim of this study was to evaluate how pre-treatment with gefitinib affects binding of astatinated EGF ((211)At-EGF) to cultured glioma U343 cells, which express high levels of EGFR. The growth of U343 cells in the presence of gefitinib was investigated, and it was found that gefitinib does not significantly inhibit the growth of these cells. Nevertheless, the uptake of (211)At-EGF in U343 cells was markedly increased (up to 3.5 times) in cells pre-treated with gefitinib (1 microM). This indicates that a combination of gefitinib treatment and radionuclide targeting to EGFR might be a useful therapeutic modality, even for patients who do not respond to treatment with gefitinib alone.
|
|
| 22. |
- Toft, Jens, et al.
(författare)
-
The optimal reference population for cardiac normality in myocardial SPET in the detection of coronary artery stenoses: patients with normal coronary angiography or subjects with low likelihood of coronary artery disease?
- 2001
-
Ingår i: European Journal Of Nuclear Medicine. - : Springer Science and Business Media LLC. - 1432-105X .- 0340-6997 .- 1619-7089. ; 28:7, s. 831-835
-
Tidskriftsartikel (refereegranskat)abstract
- Both subjects with a low likelihood for coronary artery disease (CAD) and patients with normal findings on coronary angiography have been used as reference populations in non-invasive stress testing, including myocardial perfusion scintigraphy. Both of these criteria of normality--low likelihood of CAD and normal coronary angiography--have been criticised, and consensus on this issue is lacking. The aim of this study was to compare two different reference populations by testing the performance of artificial neural networks designed to interpret myocardial scintigrams. The networks were trained on myocardial perfusion scintigrams from 87 patients with angiographically documented CAD and on studies from one of two different reference groups: 48 patients with no signs of CAD based on angiography or 128 healthy volunteers with a likelihood for CAD <5%. The performance of the two different networks was then tested using scintigrams from a separate test group of 68 patients. Coronary angiography was used as the gold standard in this group. The network trained on patients with no signs of CAD based on angiography showed an area under the receiver operating characteristic (ROC) curve of 93%. The ROC area for the network trained on healthy volunteers was 72%, and this difference was statistically significant (P=0.03). The results of this study using artificial neural networks suggest that normal angiography should be preferred as the reference standard in myocardial scintigraphy when a patient is examined for CAD prior to possible angiography. Whether the same is true for other indications, e.g. in prognostic evaluation, is unknown.
|
|
| 23. |
|
|
| 24. |
- Xu, Jiahua, et al.
(författare)
-
Quantitative analysis of inhomogeneity in ventilation SPET
- 2001
-
Ingår i: European Journal of Nuclear Medicine. - : Springer. - 0340-6997 .- 1432-105X .- 1619-7070 .- 1619-7089. ; 28:12, s. 1795-1800
-
Tidskriftsartikel (refereegranskat)abstract
- The aim of this study was to evaluate a method for quantification of inhomogeneity in ventilation single-photon emission tomography (SPET). Nine emphysematous patients, nine life-long non-smokers and nine smokers were included in the study. The SPET investigation was performed after 50 MBq (99m)Tc-Technegas had been inhaled by each subject in the supine position. A single-head gamma camera, equipped with a general-purpose parallel-hole collimator using 64 projections (20 s each) over 360 degrees, was used. Data were acquired in 128x128 matrices. Attenuation correction was applied based upon computed tomography (CT) density maps. Lung regions of interest were delineated manually on CT images and then positioned on SPET images. Several attenuation-corrected transaxial SPET slices (thickness 1 cm, spacing 3.5 cm) were reconstructed. Each SPET slice was divided into several 2x2x1 cm(3) elements. Inhomogeneity was assessed by the coefficient of variation (CV) of the pixel counts within these elements (micro-level) and the CV of the total counts of the elements (macro-level). Micro-level CVs in non-smokers varied between 1% and 41%, whereas they were dispersed over a wide range (1%-600%) in emphysematous patients. In seven smokers, the frequency distribution of micro-level CVs was within the normal range, whereas in the other two smokers the values were between the normal range and the range in emphysematous patients. The pooled mean values of micro-level CVs and macro-level CVs in each subject clearly separated the patients from the others. Parametric images of micro-level CV indicated the localisation and severity of ventilation inhomogeneity. We conclude that the present method enables quantification and localisation of regional inhomogeneity in ventilation SPET images.
|
|
